References
- Kovacs K, Horvath E, Vidal S. Classification of pituitary adenomas. J Neurooncol 2001; 54: 121–127
- Molitch M E. Nonfunctioning pituitary tumors and pituitary incidentalomas. Endocrinol Metab Clin N Am 2008; 37: 151–171, xi
- Wright D, Shah M, Peacey S R. The insulin stress test performed by an experienced endocrine specialist nurse: a safeand reliable procedure. Clin Endocrinol (Oxf) 2007; 66: 755–756
- Pavord S R, Girach A, Price D E, Absalom S R, Falconer-Smith J, Howlett T A. A retrospective audit of the combined pituitaryfunction test, using the insulin stress test, TRH and GnRH in a district laboratory. Clin Endocrinol (Oxf) 1992; 36: 135–139
- Plumpton F S, Besser G M, Cole P V. Corticosteroid treatment and surgery. 2. The management of steroid cover. Anaesthesia 1969; 24: 12–18
- Greenwood F C, Landon J, Stamp T C. The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects. J Clin Invest 1966; 45: 429–436
- Schlechte J A. Long-term management of prolactinomas. J Clin Endocrinol Metab 2007; 92: 2861–2865
- Molitch M E. Medical management of prolactin-secreting pituitary adenomas. Pituitary 2002; 5: 55–65
- Burt M G, Ho K K. Newer options in the management of acromegaly. Intern Med J 2006; 36: 437–444
- Newell-Price J, Bertagna X, Grossman A B, Nieman L K. Cushing's syndrome. Lancet 2006; 367: 1605–1617
- Johannsson G, Filipsson H, Bergthorsdottir R, Lennernas H, Skrtic S. Long-acting hydrocortisone for glucocorticoid replacement therapy. Horm Res 2007; 68(Suppl 5)182–188
- Mah P M, Jenkins R C, Rostami-Hodjegan A, et al. Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf) 2004; 61: 367–375
- Chikada N, Imaki T, Hotta M, Sato K, Takano K. An assessment of bone mineral density in patients with Addison's disease and isolated ACTH deficiency treated with glucocorticoid. Endocr J 2004; 51: 355–360
- Agha A, Liew A, Finucane F, et al. Conventional glucocorticoid replacement overtreats adult hypopituitary patients with partial ACTH deficiency. Clin Endocrinol (Oxf) 2004; 60: 688–693
- Colao A, Vitale G, Cappabianca P, et al. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab 2004; 89: 1704–1711
- Arafah B M. Medical management of hypopituitarism in patients with pituitary adenomas. Pituitary 2002; 5: 109–117